Term ends Jan 25, 2031 · High confidence
20-year base term ends Jan 25, 2031
Held by Roche Molecular Systems, Inc.
Filed Aug 8, 2011 as application 13/205,603 · Granted Jun 4, 2019
Base term plus 378 days of patent term adjustment (USPTO delay) · capped by a resolved terminal disclaimer
Today
2011
2031
Clock starts
Jan 25, 2011
Jan 25, 2011
Term ends
Jan 25, 2031
Jan 25, 2031
Granted
Jun 4, 2019
Jun 4, 2019
base term
fee events
Updated Nov 15, 2026 · includes USPTO assignment & status data published Nov 15, 2026 and grant & fee data published Nov 10, 2026 (weekly) · how we know
378
Days of term adjustment
Read from the USPTO patent term adjustment record, not recalculated here.
Capped
Terminal disclaimer
Resolved from the filed document, referencing US 10,131,937, US 10,131,951, US 10,233,496, US 9,890,421.
1 of 2
Maintenance fees paid
Two maintenance fees can end this term early, the ones due 3.5 and 7.5 years from grant; the third one's grace period runs past the term end. This counts the ones the record shows paid.
58
Family applications on record here
Applications sharing this one's continuity chain whose file history this site holds. The family may have others.
This patent's term runs 378 days past its 20-year base term on prosecution delay. A terminal disclaimer resolved from the filed document caps it earlier. 1 of 2 maintenance fees is paid so far. Confidence: High. from the record
How we calculated this date
One row per rule, each showing its own input and what it did to the date. A step we could not verify says so instead of resolving itself.
| Step | Input | Date after this step | Confidence |
|---|---|---|---|
| Base term, 20 years from filing | Clock starts Jan 25, 2011, when application 13/013,732, the earliest non-provisional in its chain, was filed (this one was filed Aug 8, 2011) | Jan 25, 2031 | High confidence |
| Continuity chain | Every parent in the chain resolved | no change | High confidence |
| Patent term adjustment | +378 days, USPTO patent term adjustment record | Feb 7, 2032 | High confidence |
| Terminal disclaimer cap | Disclaimer resolved from the filed document (refs US 10,131,937, US 10,131,951, US 10,233,496, US 9,890,421) | capped to Jan 25, 2031 | High confidence |
| Patent term extension | None on file | no change | High confidence |
| Fee events | 1 of 2 maintenance fees paid | In force | High confidence |
| Computed term end | The steps above, in order | Jan 25, 2031 | High confidence |
This family
| Application 13/013,732 | Abandoned not computed | not computed |
| US 10,308,981 | this patent Jan 2031 | Jan 2031 |
| Application 13/205,490 | Abandoned not computed | not computed |
| Application PCT/US2011/046981 | PCT application no patent term | no patent term |
| Application PCT/US2011/046935 | PCT application no patent term | no patent term |
| US 9,890,421 | In force Jan 2031 | Jan 2031 |
| Application PCT/US2011/046976 | PCT application no patent term | no patent term |
| Application PCT/US2011/046963 | PCT application no patent term | no patent term |
8 of 58 applications in this family shown, earliest filings first. The applications whose file history this site holds. The family may have others.
Assignments
Assignment documents as recorded at the USPTO, oldest first, with the reel and frame each was recorded at. A recorded assignment is a filed document, not a statement of current ownership, and the absence of a later one is not evidence that the last one still stands.
| Recorded | Assignor | Assignee | Conveyance |
|---|---|---|---|
| Oct 24, 2011 Reel 27110, frame 947 | Sparks, Andrew; Struble, Craig; Wang, Eric; Oliphant, Arnold | Tandem Diagnostics, Inc. | Assignment of Assignor's Interest |
| Jan 6, 2012 Reel 27493, frame 542 | Tandem Technologies Inc. | Aria Diagnostics, Inc. | Change of Name |
| Apr 4, 2012 Reel 27987, frame 568 | Aria Diagnostics, Inc. | Ariosa Diagnostics, Inc. | Change of Name |
| Jul 23, 2021 Reel 56969, frame 905 | Ariosa Diagnostics, Inc. | Roche Molecular Systems, Inc. | Assignment of Assignor's Interest |
| Apr 22, 2022 Reel 59847, frame 803 | Ariosa Diagnostics, Inc. | Roche Molecular Systems, Inc. | Corrective Assignment to Correct the Correct Assignment Recordal by Removing Patent Number 8399195 Previously Recorded on Reel 056969 Frame 0905. Assignor(S) Hereby Confirms the Assignment. |
Sources
Google Patents · The patent document at USPTO · Assignment records at USPTO
USPTO account required: This application in Patent Center · USPTO's maintenance fee lookup
Maintenance fee events come from USPTO's own fee records. Its fee lookup asks for the patent number and the application number.
Free plan: 3 watched companies. Pro: unlimited.
Alerts on its grants, lapses and transfers.
What's changing
Jan 2031
Term ends Jan 25, 2031. Maintenance fees still fall due before then
Note
The 378 days of patent term adjustment (USPTO delay) are read from the USPTO record, not recalculated by us
Disclaimer cap
This term is capped by a terminal disclaimer resolved from the filed document, referencing US 10,131,937, US 10,131,951, US 10,233,496, US 9,890,421.
Citations
303
later US patents cite this one
That is top 1% of utility patents granted in 2019 in our data, the only group it is compared against.
How we rank
Every date shows its work: the base term, any term adjustment or extension, any disclaimer cap, and the maintenance fee record, each with a confidence tier. How this record was built
Computed patent terms end on the dates shown. Related patents and pending applications may cover overlapping subject matter.
In force means the term is running and no lapse is on record. It is not a finding that the patent is valid.